Mashup Score: 39
The LancetPatients with cancer are at greater risk of severe COVID-19 and have been prioritised for COVID-19 vaccination globally. We previously showed that following two
See more from The Lancet
Patients with cancer are at greater risk of severe #COVID19. In a research letter, @fendler_annika & colleagues evaluate neutralising antibody responses against #omicron following 3 doses of COVID-19 vaccine in patients with cancer. #CAPTUREStudy https://t.co/tTKHZQVxPV - view on twitter